COVID-19 fears continue to roil markets

Markets entered correction territory on Thursday as COVID-19 outbreaks beyond China stoked investor fears, with the broader markets tumbling again and dragging biopharma with it.

The Dow Jones Industrial Index, NASDAQ Composite and S&P 500 each slid at least 4.4%. The major biopharma indices were hit nearly as hard, with the NASDAQ Biotechnology Index (NBI) off 4.1%, while the BioCentury 100 dropped 4.42% and the S&P Biotech ETF (XBI) and NYSE Arca Biotech index (BTK) were off 4.3% and 3.6%, respectively...